Torrent Pharmaceuticals has received approval from the UK’s Medicines and Healthcare Products Regulatory Agency to sell the generic version of Abilify tablets, used in treatment of mental disorders. While the drug is primarily used in the treatment of schizophrenia and bipolar disorder, it is also used as an add-on treatment in major depressive disorder, tic disorders and irritability associated with autism. Investors will track the development.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.